Cipla launches Hepatitis C drug & other Top Corporate News

India Infoline News Service | Mumbai | December 22, 2015 08:47 IST

Check out the most important news stories which captured the headlines at the corporate level in India and internationally.

Corporate News
Cipla announced the launch of generic version of anti-hepatitis drug Ledipasvir-Sofosbuvir in the domestic market. The drug is used for treating hepatitis C virus. (BS)

Reliance Communications has sold about 150 residential flats in Navi Mumbai for Rs3.3bn. RCom has already received more than 50% of the sale proceeds and the balance amount will be realized in the next 2-3 months. (ET)

SpiceJet has, for the seventh consecutive month, reported a seat factor of above 90% in November. As against this, rival IndiGo recorded a seat factor of 83.9% in November while Air India saw its seat factor increasing to 81.7% as compared with 74.6% in October. (BS)

Sania Mirza has been roped in as a celebrity endorser for Kesh King, the leading ayurvedic hair care brand owned by Emami Ltd. (BL)

Godrej Agrovet has acquired an additional 25% stake in Hyderabad-based Creamline Dairy at an enterprise value of about Rs5.5bn, taking its total holding in the dairy firm to 51%. (ET)

Drug firm Strides Shasun has received approval from the Drug Controller General of India (DCGI) to produce a generic version of Gilead's 'Sovaldi' used for treatment of Hepatitis C. (BS)

Devendra Fadnavis handed over an “offer letter” allocating 500 acres of land in Amravati district to Raymond Group for setting up a Rs15bn textile unit in Vidarbha. (BL)

Jindal Steel and Power will resume mining coal from two of its stalled projects in Australia as it expects to get regulatory clearances from Canberra soon. The firm had to suspend operations at its Russell Vale Colliery in September because of regulatory issues. Wongawilli Colliery was shut for maintenance in August but it now needs government approvals to restart mining. (BS)

State Bank of India said it plans to raise up to Rs120bn by issuing tier-II bonds on private placement basis. (ET)


  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.